Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinomaCentral MessagePerspective
Objectives: Neoadjuvant chemoradiation has been shown to improve survival in locally advanced esophageal and gastroesophageal junction cancer. The purpose of our study was to examine the effects of posttreatment persistent lymph node (LN) disease on overall survival (OS) and recurrence in patients w...
Main Authors: | Apostolos Kandilis, MD, Carlos Bravo Iniguez, MD, Hassan Khalil, MD, Emanuele Mazzola, MS, PhD, Michael T. Jaklitsch, MD, Scott J. Swanson, MD, Raphael Bueno, MD, Jon O. Wee, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | JTCVS Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666273620301789 |
Similar Items
-
The impact of refusing esophagectomy for treatment of locally advanced esophageal adenocarcinomaCentral MessagePerspective
by: Lye-Yeng Wong, MD, et al.
Published: (2023-12-01) -
Intraoperative challenges after induction therapy for non–small cell lung cancer: Effect of nodal disease on technical complexityCentral MessagePerspective
by: Hope A. Feldman, MD, et al.
Published: (2022-12-01) -
Complete Response after Neoadjuvant Therapy in Rectal Cancer- Does T0 Mean N0?
by: Rajat Raghunath, et al.
Published: (2017-11-01) -
Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant Chemotherapy
by: Guillaume Ploussard, et al.
Published: (2020-06-01) -
“Left ventricular” AV nodal reentrant tachycardia: Case report and review of the literature
by: John Green, MD, et al.
Published: (2016-09-01)